Scientific considerations in the regulatory approval of generic (or biosimilar) version of enoxaparin sodium – A lifesaving carbohydrate polymer-Reference-Cited by-同舟云学术

Scientific considerations in the regulatory approval of generic (or biosimilar) version of enoxaparin sodium – A lifesaving carbohydrate polymer

Published:2023-09 Issue: Volume:143 Page:105446
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Iqbal Zarina,Sadaf Saima^ORCID

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference53 articles.

1. Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity;Achour;Carbohydr. Polym.,2013

2. Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection - a cohort study;Albani;EClinicalMedicine,2020

3. Modernization of enoxaparin molecular weight determination using homogeneous standards;Arnold;Pharmaceuticals,2017

4. Hydrophilic interaction liquid chromatography (HILIC) - a powerful separation technique;Buszewski;Anal. Bioanal. Chem.,2012

5. Determination of the primary structures of heparin- and heparan sulfate-derived oligosaccharides using band-selective homonuclear- decoupled two-dimensional H-1 NMR experiments;Chuang;Anal. Chem.,2001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obtaining the Enoxaparin Sodium Substance Equivalent to the Original Clexane® and Lovenox®. The Selection of Technological Parameters and Optimization of the “Greenness” of the Purification Stage;Journal of Organic and Pharmaceutical Chemistry;2023-11-07